icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 20 Aug 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

Drug Clinical Trials List

Display 151 - 160 from 768
Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
A randomized, sham-controlled, double-blind study to evaluate the efficacy and safety of intrathecal (IT) OAV101 in patients with later onset Type 2 spinal muscular atrophy (SMA) who are ≥ 2 to < 18 years of age, treatment naive, sitting, and never ambulatory Novartis Saudi Limited Ongoing OAV101 (formerly AVXS-101) 3 COAV101B12301 King Faisal Specialist Hospital and Research Center (Riyadh),King Fahad Specialist Hospital (Dammam)
Timing Of Thyroxine Dose In Ramadan KAIMRC Ongoing Levothyroxine 4 ICT22J/001 King Abdulaziz Medical City NG (Jeddah)
Fluids in septic shock (FISSH) KAIMRC Ongoing RINGER'S-LACTATE SOLUTION 3 SCT21R/001/01 King Abdulaziz Medical City NG (Riyadh)
Phase II study of neoadjuvant hormonal therapy guided by interval Ki67 testing in hormonal receptor-positive, HER2-negative breast cancer. King Abdullah Medical City (Makkah) Ongoing Letrozole (Femaplex) 2 20-718 King Abdullah Medical City (Makkah)
Modern Treatment of Inhibitor-PositiVe PATiEnts with Haemophilia A – An International Low-Interventional Pragmatic Investigator Initiated Trial Octapharma AG Ongoing Octanate, Wilate, Hemlibra, NovoSeven, Feiba 4 MOTIVATE King Abdulaziz Medical City NG (Riyadh)
Phase 1b/2 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia Onyx Therapeutics, Inc., an Amgen Inc. Subsidiary Terminated Carfilzomib 2 20140106 King Fahad Medical City (Riyadh)
The Effectiveness of Sixteen Milligrams of Dexamethasone in Preventing Postoperative Nausea and Vomiting After Cesarean Delivery Under Neuroaxial Anesthesia King Khalid University Hospital Rejected Dexamethasone sodium phosphate 4 E-21-6388 King Khalid University Hospital (Riyadh)
Randomized, Prospective, Phase II clinical study of Intrathecal Morphine for patients undergoing elective Lumbar Spine Surgery under general anesthesia King Abdullah Medical City (Makkah) Ongoing MORPHINE SULPHATE 2 19-597 King Abdullah Medical City (Makkah)
Treatment of Cardio Vascular Disease with low dose Rivaroxaban in Advanced Chronic Kidney Disease(TRACK) KAIMRC Ongoing Rivaroxaban 3 SCT21R/008/10 King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah),King Khalid University Hospital (Riyadh)
Comparison of Three Times of Thyroid Hormone Replacement During Fasting the Month of Ramadan Among Patients with Total Thyroidectomy in Saudi Population: A Randomized Controlled Trial. King Fahd University Hospital Ongoing levothyroxine 4 E-21-5765 King Khalid University Hospital (Riyadh)